The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing...
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of bedaquiline and delamanid was a critical development in the MDR-TB treatment landscape. However, despite their availability for routine programmatic use, the uptake of these drugs has re...
Alternative Titles
Full title
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5c779cd6d31044b88b3e17992de23a3a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5c779cd6d31044b88b3e17992de23a3a
Other Identifiers
ISSN
1471-2334
E-ISSN
1471-2334
DOI
10.1186/s12879-019-4378-4
